Meeting 1: Prevention of HIV Infection among Injecting Drug Users in High Risk Countries
- When:
- Monday, December 19, 2005 - Tuesday, December 20, 2005 (8:00 AM)
- Topic(s):
- Diseases, Global Health, Public Health, Substance Abuse and Mental Health
- Activity:
- Prevention of HIV Infection among Injecting Drug Users in High Risk Countries
- Board(s):
- Board on Global Health
OPEN SESSION
9:00 - 9:15 a.m. Welcome, Introductions, and Opening Statement
Hugh Tilson, M.D., Dr.PH.
Committee Chair
9:15 - 9:45 a.m. Charge to the committee
Peter Piot, M.D., Ph.D.
Executive Director, UNAIDS
Under Secretary-General of the United Nations
9:45 - 10:15a.m. Overview of addiction
Michael Farrell, MRCPsych
Reader in Addiction Psychiatry, National Addiction Centre
Institute of Psychiatry
King's College, London
10:15 - 11:00 a.m. Epidemiology of HIV/AIDS among IDUs in High-Risk Countries and the Global Response
Dr. Peter Ghys
Acting Associate Director, Epidemic Monitoring and Prevention, Department of Policy, Evidence and Partnerships
UNAIDS
Catherine Anita Hankins, MD, MSc, FRCPC
Associate Director of Policy, Evidence and Partnerships
Chief Scientific Adviser
UNAIDS
11:00 - 11:15 a.m. Break
11:15a.m. - 12:45 pm Evidence regarding HIV Prevention for IDUs
Overview:
Gerry V. Stimson PhD
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association
Review of needle and syringe exchange programs:
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia
Review of needle and syringe exchange programs:
Kerstin Kall, MD, Ph.D.
Clinic for Dependency Disorders
University Hospital
Linkoping, Sweden
Review of drug treatment strategies:
Michael Farrell, MRCPsych
Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry
King's College, London
12:45 - 1:45 p.m. Lunch
1:45 - 3:15p.m. Country Perspectives Panel – Asian and Pacific countries
Fujie Zhang, M.D.
Director, Division of Treatment and Care
National Center for AIDS-STD Control and Prevention
Chinese Center for Disease of Control and Prevention
Adeeba Kamarulzaman, MBBS, FRACP
Head, Infectious Diseases Unit
Department of Medicine
University of Malaya Medical Centre
Malaysia
Chris Beyrer, MD, MPH
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health
(discussing Thailand)
3:15 - 3:30p.m. Break
3:30 - 5:45 p.m. Country Perspectives Panel–Former Soviet States, Central and Eastern European countries
Saulius Caplinskas, M.D., Ph.D.
Director, Lithuanian AIDS Centre
Associate Professor, Mykolas Romeris University
Monica Ciupagea M.D.
Program Officer
International Harm Reduction Development Program
Open Society Institute, Budapest
Dr. Oleg Tchestnov
Deputy Director of the International Department
Ministry of Health, Russia
Ksenia Eroshina, MPH, Ph.D.
Head of Monitoring & Evaluation Department
Open Health Institute, Moscow, Russia
Alexey Mazus M.D.
Head of Moscow AIDS Center
Inga Upmace, M.D.
Deputy Director, AIDS Prevention Center, Latvia
Steering Commitee member of CEE-HRN (Central and Eastern Europe Harm Reduction Network)
Lily Hyde
Harm reduction and IEC Consultant
International HIV/AIDS Alliance in Ukraine
6:30 p.m. Reception for all meeting participants at the ILO building, hosted by UNAIDS
December 20th
OPEN SESSION
8:30 - 10:00 a.m. Lessons Learned– Experiences in the U.S., Canada, Australia, and Western European countries
Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute,
Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health
Albert Einstein College of Medicine, New York
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia
Roel A. Coutinho, M.D., Ph.D.
Director, Centre for Infectious Disease Control
National Institute for Health and the Environment
The Netherlands
Gerry V. Stimson PhD
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association
10:00a.m. - 10:15a.m. Break
10:15a.m. - 12:30p.m. Illicit drug policies and the HIV epidemic
Andrew Ball MB BS, FAChAM
Senior Strategy and Operations Advisor
Department of HIV/AIDS
World Health Organization
Mr. Christian Kroll
Senior Coordinator, HIV/AIDS Unit
Global Coordinator on HIV/AIDS
UNODC
Chris Beyrer, MD, MPH
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health
Mr. Tomas Hallberg
Director, European Cities against Drugs (ECAD)
Stockholm, Sweden
Mr. George Zazulin
St. Petersburg Regional Director, ECAD, Russia
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia
Ms. Raminta Stuikyte
Director, Central and Eastern European Harm Reduction Network
12:30 - 1:30 p.m. Lunch
1:30 - 2:30pm Community Perspectives
Mr. Loon Gangte (unable to attend)
President, Delhi Network of Positive People, India
Regional Coordinator for South Asia
Collaborative Fund for HIV treatment Preparedness
Mr. Samuel Nugraha
Partnership and Network Assistant
UNAIDS Secretariat Indonesia
2:30 - 3:00 p.m. Methodological considerations in evaluating evidence
Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute,
Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health
Albert Einstein College of Medicine, New York
3:00 - 3:30 p.m. Public comments
3:30 p.m. Adjourn open session